reglab/housing_qa huggingface dataset:
UT Code § 26-55-106 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 55 - Opiate Overdose Response Act|Section 106 - Overdose outreach providers.

 Effective 5/9/2017  26-55-106. Overdose outreach providers.  Notwithstanding Sections 58-1-501, 58-17b-501, and 58-17b-502:  (1) an overdose outreach provider may:   (a) obtain an opiate antagonist dispensed on prescription by:   (i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or     (ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act;       (b) store the opiate antagonist; and     (c) furnish the opiate antagonist:   (i)   (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or     (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and       (ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and         (2) when furnishing an opiate antagonist under Subsection (1), an overdose outreach provider:   (a) shall also furnish to the recipient of the opiate antagonist:   (i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or     (ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and       (b) may provide additional instruction on how to recognize and respond appropriately to an opiate-related drug overdose event.      Amended by Chapter 392, 2017 General Session
UT Code § 26-55-108 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 55 - Opiate Overdose Response Act|Section 108 - Coprescription guidelines.

 Effective 5/8/2018  26-55-108. Coprescription guidelines.    (1) As used in this section:   (a) "Controlled substance prescriber" means the same as that term is defined in Section 58-37-6.5.     (b) "Coprescribe" means to issue a prescription for an opiate antagonist with a prescription for an opiate.       (2) The department shall, in consultation with the Physicians Licensing Board created in Section 58-67-201, the Osteopathic Physician and Surgeon's Licensing Board created in Section 58-68-201, and the Department of Occupational and Professional Licensing created in Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.    Amended by Chapter 38, 2018 General Session
UT Code § 26-55-109 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 55 - Opiate Overdose Response Act|Section 109 - Opiate abuse prevention pamphlet.

 Effective 5/8/2018  26-55-109. Opiate abuse prevention pamphlet.    (1) As funding is available, the department shall produce and distribute, in conjunction with the Division of Substance Abuse and Mental Health, a pamphlet about opiates that includes information regarding:   (a) the risk of dependency and addiction;     (b) methods for proper storage and disposal;     (c) alternative options for pain management;     (d) the benefits of and ways to obtain naloxone; and     (e) resources if the patient believes that the patient has a substance abuse disorder.       (2) The pamphlet described in Subsection (1) shall be:   (a) evaluated periodically for effectiveness at conveying necessary information and revised accordingly;     (b) written in simple and understandable language; and     (c) available in English and other languages that the department determines to be appropriate and necessary.      Enacted by Chapter 145, 2018 General Session
UT Code § 26-57-101 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 57 - Electronic Cigarette Product and Nicotine Product Regulation Act|Section 101 - Title.

 Effective 5/28/2021  26-57-101. Title.  This chapter is known as the "Electronic Cigarette Product and Nicotine Product Regulation Act." Amended by Chapter 12, 2021 Special Session 1
UT Code § 26-57-102 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 57 - Electronic Cigarette Product and Nicotine Product Regulation Act|Section 102 - Definitions.

 Effective 5/28/2021  26-57-102. Definitions.  As used in this chapter:  (1) "Electronic cigarette" means the same as that term is defined in Section 76-10-101.     (2) "Electronic cigarette product" means the same as that term is defined in Section 76-10-101.     (3) "Electronic cigarette substance" means the same as that term is defined in Section 76-10-101.     (4) "Local health department" means the same as that term is defined in Section 26A-1-102.     (5) "Manufacture" includes:   (a) to cast, construct, or make electronic cigarettes; or     (b) to blend, make, process, or prepare an electronic cigarette substance.       (6) "Manufacturer sealed electronic cigarette substance" means an electronic cigarette substance that is sold in a container that:   (a) is prefilled by the electronic cigarette substance manufacturer; and     (b) the electronic cigarette manufacturer does not intend for a consumer to open.       (7) "Manufacturer sealed electronic cigarette product" means:   (a) an electronic cigarette substance or container that the electronic cigarette manufacturer does not intend for a consumer to open or refill; or     (b) a prefilled electronic cigarette as that term is defined in Section 76-10-101.       (8) "Nicotine" means the same as that term is defined in Section 76-10-101.     (9) "Nicotine product" means the same as that term is defined in Section 76-10-101.    Amended by Chapter 12, 2021 Special Session 1
UT Code § 26-57-103 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 57 - Electronic Cigarette Product and Nicotine Product Regulation Act|Section 103 - Electronic cigarette products -- Labeling -- Requirements to sell -- Advertising.

 Effective 5/28/2021  26-57-103. Electronic cigarette products -- Labeling -- Requirements to sell -- Advertising.    (1) The department shall, in consultation with a local health department and with input from members of the public, establish by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the requirements to sell an electronic cigarette substance that is not a manufacturer sealed electronic cigarette substance regarding:   (a) labeling;     (b) nicotine content;     (c) packaging; and     (d) product quality.       (2) On or before January 1, 2021, the department shall, in consultation with a local health department and with input from members of the public, establish by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the requirements to sell a manufacturer sealed electronic cigarette product regarding:   (a) labeling;     (b) nicotine content;     (c) packaging; and     (d) product quality.       (3)   (a) A person may not sell an electronic cigarette substance unless the electronic cigarette substance complies with the requirements established by the department under Subsection (1).     (b) Beginning on July 1, 2021, a person may not sell a manufacturer sealed electronic cigarette product unless the manufacturer sealed electronic cigarette product complies with the requirements established by the department under Subsection (2).       (4)   (a) A local health department may not enact a rule or regulation regarding electronic cigarette substance labeling, nicotine content, packaging, or product quality that is not identical to the requirements established by the department under Subsections (1) and (2).     (b) Except as provided in Subsection (4)(c), a local health department may enact a rule or regulation regarding electronic cigarette substance manufacturing.     (c) A local health department may not enact a rule or regulation regarding a manufacturer sealed electronic cigarette product.       (5) A person may not advertise an electronic cigarette product as a tobacco cessation device.    Amended by Chapter 12, 2021 Special Session 1
UT Code § 26-57-104 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 57 - Electronic Cigarette Product and Nicotine Product Regulation Act|Section 104 - Labeling of nicotine products containing nicotine.

 Effective 7/1/2020  26-57-104. Labeling of nicotine products containing nicotine.    (1) Any nicotine product shall contain the statement described in Subsection (2) if the nicotine product:   (a)   (i) is not a tobacco product as defined in 21 U.S.C. Sec. 321 and related federal regulations; or     (ii) is not otherwise required under federal or state law to contain a nicotine warning; and       (b) contains nicotine.       (2) A statement shall appear on the exterior packaging of a nicotine product described in Subsection (1) as follows: "This product contains nicotine."    Enacted by Chapter 347, 2020 General Session
UT Code § 26-58-101 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 58 - Children with Heart Disease Support Restricted Account|Section 101 - Title.

 Effective 10/1/2016  26-58-101. Title.  This chapter is known as the "Children with Heart Disease Support Restricted Account." Enacted by Chapter 71, 2016 General Session
UT Code § 26-58-102 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 58 - Children with Heart Disease Support Restricted Account|Section 102 - Children with Heart Disease Support Restricted Account.

 Effective 10/1/2016  26-58-102. Children with Heart Disease Support Restricted Account.    (1) As used in this section, "account" means the Children with Heart Disease Support Restricted Account created in Subsection (2).     (2) There is created in the General Fund a restricted account known as the "Children with Heart Disease Support Restricted Account."     (3) The account shall be funded by:   (a) contributions deposited into the account in accordance with Section 41-1a-422;     (b) private contributions;     (c) donations or grants from public or private entities; and     (d) interest and earnings on fund money.       (4) The Legislature shall appropriate money in the account to the department.     (5) Upon appropriation, the department shall distribute funds in the account to one or more charitable organizations that:   (a) qualify as being tax exempt under Section 501(c)(3), Internal Revenue Code; and     (b) have programs that provide awareness, education, support services, and advocacy for and on behalf of children with heart disease.       (6)   (a) An organization described in Subsection (5) may apply to the department to receive a distribution in accordance with Subsection (5).     (b) An organization that receives a distribution from the department in accordance with Subsection (5) shall expend the distribution only to provide awareness, education, support services, and advocacy for and on behalf of children with heart disease.     (c) In accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the department may make rules providing procedures for an organization to apply to the department to receive a distribution under Subsection (5).       (7) In accordance with Section 63J-1-602.1, appropriations from the account are nonlapsing.    Enacted by Chapter 71, 2016 General Session
UT Code § 26-60-101 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 60 - Telehealth Act|Section 101 - Title.

 Effective 5/9/2017  26-60-101. Title.  This chapter is known as the "Telehealth Act." Enacted by Chapter 241, 2017 General Session  Technically renumbered to avoid duplication of section number also enacted in HB345, Chapter 413.
UT Code § 26-60-102 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 60 - Telehealth Act|Section 102 - Definitions.

 Effective 5/12/2020  26-60-102. Definitions.  As used in this chapter:  (1) "Asynchronous store and forward transfer" means the transmission of a patient's health care information from an originating site to a provider at a distant site.     (2) "Distant site" means the physical location of a provider delivering telemedicine services.     (3) "Originating site" means the physical location of a patient receiving telemedicine services.     (4) "Patient" means an individual seeking telemedicine services.     (5)   (a) "Patient-generated medical history" means medical data about a patient that the patient creates, records, or gathers.     (b) "Patient-generated medical history" does not include a patient's medical record that a healthcare professional creates and the patient personally delivers to a different healthcare professional.       (6) "Provider" means an individual who is:   (a) licensed under Title 26, Chapter 21, Health Care Facility Licensing and Inspection Act;     (b) licensed under Title 58, Occupations and Professions, to provide health care; or     (c) licensed under Title 62A, Chapter 2, Licensure of Programs and Facilities.       (7) "Synchronous interaction" means real-time communication through interactive technology that enables a provider at a distant site and a patient at an originating site to interact simultaneously through two-way audio and video transmission.     (8) "Telehealth services" means the transmission of health-related services or information through the use of electronic communication or information technology.     (9) "Telemedicine services" means telehealth services:   (a) including:   (i) clinical care;     (ii) health education;     (iii) health administration;     (iv) home health;     (v) facilitation of self-managed care and caregiver support; or     (vi) remote patient monitoring occurring incidentally to general supervision; and       (b) provided by a provider to a patient through a method of communication that:   (i)   (A) uses asynchronous store and forward transfer; or     (B) uses synchronous interaction; and       (ii) meets industry security and privacy standards, including compliance with:   (A) the federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110 Stat. 1936, as amended; and     (B) the federal Health Information Technology for Economic and Clinical Health Act, Pub. L. No. 111-5, 123 Stat. 226, 467, as amended.          Amended by Chapter 119, 2020 General Session
UT Code § 26-60-104 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 60 - Telehealth Act|Section 104 - Enforcement.

 Effective 5/9/2017  26-60-104. Enforcement.    (1) The Division of Occupational and Professional Licensing created in Section 58-1-103 is authorized to enforce the provisions of Section 26-60-103 as it relates to providers licensed under Title 58, Occupations and Professions.     (2) The department is authorized to enforce the provisions of Section 26-60-103 as it relates to providers licensed under this title.     (3) The Department of Human Services created in Section 62A-1-102 is authorized to enforce the provisions of Section 26-60-103 as it relates to providers licensed under Title 62A, Chapter 2, Licensure of Programs and Facilities.    Enacted by Chapter 241, 2017 General Session  Technically renumbered to avoid duplication of section number also enacted in HB345, Chapter 413.
UT Code § 26-60-105 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 60 - Telehealth Act|Section 105 - Study by Public Utilities, Energy, and Technology Interim Committee and Health Reform Task Force.

 Effective 5/14/2019  26-60-105. Study by Public Utilities, Energy, and Technology Interim Committee and Health Reform Task Force.  The Legislature's Public Utilities, Energy, and Technology Interim Committee and Health Reform Task Force shall receive the reports required in Sections 26-18-13.5 and 49-20-414 and, during the 2019 interim, study:  (1) the result of the reimbursement requirement described in Sections 26-18-13.5 and 49-20-414;     (2) practices and efforts of private health care facilities, health care providers, self-funded employers, third-party payors, and health maintenance organizations to reimburse for telehealth services;     (3) existing and potential uses of telehealth and telemedicine services;     (4) issues of reimbursement to a provider offering telehealth and telemedicine services; and     (5) potential rules or legislation related to:   (a) providers offering and insurers reimbursing for telehealth and telemedicine services; and     (b) increasing access to health care, increasing the efficiency of health care, and decreasing the costs of health care.      Amended by Chapter 249, 2019 General Session
UT Code § 26-64-101 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 64 - Family Planning Access Act|Section 101 - Title.

 Effective 5/8/2018  26-64-101. Title.  This chapter is known as the "Family Planning Access Act." Enacted by Chapter 295, 2018 General Session  Technically renumbered to avoid duplication of section number also enacted in HB 324, Chapter 231.
UT Code § 26-64-102 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 64 - Family Planning Access Act|Section 102 - Definitions.

 Effective 5/8/2018  26-64-102. Definitions.  As used in this chapter:  (1) "Dispense" means the same as that term is defined in Section 58-17b-102.     (2) "Division" means the Division of Occupational and Professional Licensing created in Section 58-1-103.     (3) "Local health department" means:   (a) a local health department, as defined in Section 26A-1-102; or     (b) a multicounty local health department, as defined in Section 26A-1-102.       (4) "Patient counseling" means the same as that term is defined in Section 58-17b-102.     (5) "Pharmacist" means the same as that term is defined in Section 58-17b-102.     (6) "Pharmacy intern" means the same as that term is defined in Section 58-17b-102.     (7) "Physician" means the same as that term is defined in Section 58-67-102.     (8) "Prescribe" means the same as that term is defined in Section 58-17b-102.     (9)   (a) "Self-administered hormonal contraceptive" means a self-administered hormonal contraceptive that is approved by the United States Food and Drug Administration to prevent pregnancy.     (b) "Self-administered hormonal contraceptive" includes an oral hormonal contraceptive, a hormonal vaginal ring, and a hormonal contraceptive patch.     (c) "Self-administered hormonal contraceptive" does not include any drug intended to induce an abortion, as that term is defined in Section 76-7-301.      Enacted by Chapter 295, 2018 General Session  Technically renumbered for proper placement.
UT Code § 26-64-103 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 64 - Family Planning Access Act|Section 103 - Voluntary participation.

 Effective 5/8/2018  26-64-103. Voluntary participation.  This chapter does not create a duty or standard of care for a person to prescribe or dispense a self-administered hormonal contraceptive. Enacted by Chapter 295, 2018 General Session  Technically renumbered for proper placement.
UT Code § 26-64-104 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 64 - Family Planning Access Act|Section 104 - Authorization to dispense self-administered hormonal contraceptives.

 Effective 5/8/2018  26-64-104. Authorization to dispense self-administered hormonal contraceptives.  Notwithstanding Title 58, Chapter 17b, Pharmacy Practice Act, a person licensed under Title 58, Chapter 17b, Pharmacy Practice Act, to dispense a self-administered hormonal contraceptive may dispense the self-administered hormonal contraceptive:  (1) to a patient who is 18 years old or older;     (2) pursuant to a standing prescription drug order made in accordance with Section 26-64-105;     (3) without any other prescription drug order from a person licensed to prescribe a self-administered hormonal contraceptive; and     (4) in accordance with the dispensing guidelines in Section 26-64-106.    Enacted by Chapter 295, 2018 General Session  Technically renumbered for proper placement.
UT Code § 26-64-105 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 64 - Family Planning Access Act|Section 105 - Standing prescription drug orders for a self-administered hormonal contraceptive.

 Effective 5/8/2018  26-64-105. Standing prescription drug orders for a self-administered hormonal contraceptive.  A physician who is licensed to prescribe a self-administered hormonal contraceptive, including a physician acting in the physician's capacity as an employee of the department, or a medical director of a local health department, may issue a standing prescription drug order authorizing the dispensing of the self-administered hormonal contraceptive under Section 26-64-104 in accordance with a protocol that:  (1) requires the physician to specify the persons, by professional license number, authorized to dispense the self-administered hormonal contraceptive;     (2) requires the physician to review at least annually the dispensing practices of those authorized by the physician to dispense the self-administered hormonal contraceptive;     (3) requires those authorized by the physician to dispense the self-administered hormonal contraceptive to make and retain a record of each person to whom the self-administered hormonal contraceptive is dispensed, including:   (a) the name of the person;     (b) the drug dispensed; and     (c) other relevant information; and       (4) is approved by the department by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act.    Enacted by Chapter 295, 2018 General Session  Technically renumbered for proper placement.